Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Priya D, Velu"'
Autor:
James P. Solomon, Carlos Munoz-Zuluaga, Cheyanne Slocum, Alicia Dillard, Lin Cong, Jiajing Wang, Neal Lindeman, Michael Kluk, Benjamin Liechty, David Pisapia, Hanna Rennert, Priya D. Velu
Publikováno v:
Diagnostic Pathology, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract IDH1 and IDH2 mutational status is a critical biomarker with diagnostic, prognostic, and treatment implications in glioma. Although IDH1 p.R132H-specific immunohistochemistry is available, it is unable to identify other mutations in IDH1/2.
Externí odkaz:
https://doaj.org/article/f02cae229f3b4be88d7e1184225ddd66
Autor:
Ami Patel, Erika Hissong, Lucelina Rosado, Robert Burkhardt, Lin Cong, Susan A. Alperstein, Momin T. Siddiqui, Hyeon Jin Park, Wei Song, Priya D. Velu, Hanna Rennert, Jonas J. Heymann
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Cell-free DNA (cfDNA) extracted from diverse specimen types has emerged as a high quality substrate for molecular tumor profiling. Analytical and pre-analytical challenges in the utilization of cfDNA extracted from pleural effusion supernatant (PES)
Externí odkaz:
https://doaj.org/article/3b4a84d7a57a4e81bbd153f328da6866
Autor:
Pranjal Vaidya, BS, Kaustav Bera, MD, Amit Gupta, MD, Xiangxue Wang, PhD, Germán Corredor, PhD, Pingfu Fu, PhD, Niha Beig, MS, Prateek Prasanna, PhD, Pradnya D Patil, MD, Priya D Velu, MD, Prabhakar Rajiah, MD, Robert Gilkeson, MD, Michael D Feldman, MD, Humberto Choi, MD, Vamsidhar Velcheti, MD, Anant Madabhushi, ProfPhD
Publikováno v:
The Lancet: Digital Health, Vol 2, Iss 3, Pp e116-e128 (2020)
Summary: Background: Use of adjuvant chemotherapy in patients with early-stage lung cancer is controversial because no definite biomarker exists to identify patients who would receive added benefit from it. We aimed to develop and validate a quantita
Externí odkaz:
https://doaj.org/article/e5aca4df135e47e1a54b8e95e0678404
Autor:
Priya D. Velu, Allison Cushman-Vokoun, Mark D. Ewalt, Harriet Feilotter, Julie M. Gastier-Foster, Rashmi S. Goswami, Jennifer Laudadio, Randall J. Olsen, Rebecca Johnson, Anthony Schlinsog, Aaron Douglas, Tyler Sandersfeld, Karen L. Kaul
Publikováno v:
The Journal of Molecular Diagnostics. 24:825-840
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c3e0fc9b760b9333bb794747619ce8c
https://doi.org/10.1016/j.jmoldx.2022.04.011
https://doi.org/10.1016/j.jmoldx.2022.04.011
Autor:
Anant Madabhushi, Vamsidhar Velcheti, Michael Feldman, Pingfu Fu, Kaustav Bera, Mehdi Alilou, German Corredor, Rajat Thawani, Priya D. Velu, Pradnya Patil, Amit Gupta, Prateek Prasanna, Mohammadhadi Khorrami
Supplemental Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b712d959f6a03378cf4a8cada79d186
https://doi.org/10.1158/2326-6066.22543101
https://doi.org/10.1158/2326-6066.22543101
Autor:
Anant Madabhushi, Vamsidhar Velcheti, Michael Feldman, Pingfu Fu, Kaustav Bera, Mehdi Alilou, German Corredor, Rajat Thawani, Priya D. Velu, Pradnya Patil, Amit Gupta, Prateek Prasanna, Mohammadhadi Khorrami
Supplemental Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81e33972f1525896ee459d199174f40e
https://doi.org/10.1158/2326-6066.22543104
https://doi.org/10.1158/2326-6066.22543104
Autor:
Anant Madabhushi, Vamsidhar Velcheti, Michael Feldman, Pingfu Fu, Kaustav Bera, Mehdi Alilou, German Corredor, Rajat Thawani, Priya D. Velu, Pradnya Patil, Amit Gupta, Prateek Prasanna, Mohammadhadi Khorrami
No predictive biomarkers can robustly identify patients with non–small cell lung cancer (NSCLC) who will benefit from immune checkpoint inhibitor (ICI) therapies. Here, in a machine learning setting, we compared changes (“delta”) in the radiomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce126f067c9169a2263c042030a37df
https://doi.org/10.1158/2326-6066.c.6550137.v1
https://doi.org/10.1158/2326-6066.c.6550137.v1
Autor:
Priya D Velu, Timothy eMullen, Eunho eNoh, Matthew eValdivia, Howard ePoizner, Yoram eBaram, Virginia R de Sa
Publikováno v:
Frontiers in Neurology, Vol 4 (2014)
Freezing of gait (FOG) is an elusive phenomenon that debilitates a large number of Parkinson’s disease (PD) patients regardless of stage of disease, medication status, or DBS implantation. Sensory cues, especially visual feedback cues, have been sh
Externí odkaz:
https://doaj.org/article/04cf587cb20543d0a9f2d2d369cf7944
Autor:
Zane D. Amenhotep, Wayne B. Anderson, Jason M. Baron, Carey-Ann D. Burnham, Jing Cao, Janine D. Cook, Gyorgy Csako, Sarah Delaney, Anand S. Dighe, Shu-Ling Fan, Wieslaw Furmaga, Putuma P. Gqamana, Dina N. Greene, Neil Harris, Ibrahim Hashim, Erika M. Hissong, Paul J. Jannetto, Michael Karasick, Adil I. Khan, Rasoul A. Koupaei, Kent Lewandrowski, Chuanyi Mark Lu, Maximo J. Marin, Yvette McCarter, Qing H. Meng, James H. Nichols, Anthony Okorodudu, Octavia M. Peck Palmer, Hanna Rennert, Luke Rodda, Lusia Sepiashvili, Christine L.H. Snozek, Carole A. Spencer, John Toffaletti, Nam Tran, Greg Tsongalis, Priya D. Velu, Jeffrey Whitman, Xander M.R. van Wijk, Alison Woodworth, Alan H.B. Wu, Melanie L. Yarbrough, He Sarina Yang, Brandy Young, Y. Victoria Zhang, Zhen Zhao
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0b4719bf4bf55d79786bbce135c12ad
https://doi.org/10.1016/b978-0-12-822093-1.09989-0
https://doi.org/10.1016/b978-0-12-822093-1.09989-0